These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36778517)

  • 1. The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020.
    Wewer MD; Arp L; Sarikaya M; Felding OK; Vind I; Pedersen G; Mertz-Nielsen A; Kiszka-Kanowitz M; Boysen T; Theede K; Petersen AM; Nordgaard-Lassen I; Bendtsen F; Burisch J
    Crohns Colitis 360; 2022 Oct; 4(4):otac041. PubMed ID: 36778517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases - a Danish nationwide cohort study.
    Zhao M; Sall Jensen M; Knudsen T; Kelsen J; Coskun M; Kjellberg J; Burisch J
    Aliment Pharmacol Ther; 2022 Mar; 55(5):541-557. PubMed ID: 34881439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
    Burisch J; Zammit SC; Ellul P; Turcan S; Duricova D; Bortlik M; Andersen KW; Andersen V; Kaimakliotis IP; Fumery M; Gower-Rousseau C; Girardin G; Valpiani D; Goldis A; Brinar M; Čuković-Čavka S; Oksanen P; Collin P; Barros L; Magro F; Misra R; Arebi N; Eriksson C; Halfvarson J; Kievit HAL; Pedersen N; Kjeldsen J; Myers S; Sebastian S; Katsanos KH; Christodoulou DK; Midjord J; Nielsen KR; Kiudelis G; Kupcinskas L; Nikulina I; Belousova E; Schwartz D; Odes S; Salupere R; Carmona A; Pineda JR; Vegh Z; Lakatos PL; Langholz E; Munkholm P;
    J Gastroenterol Hepatol; 2019 Jun; 34(6):996-1003. PubMed ID: 30562421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric inflammatory bowel disease in Greece: 30-years experience of a single center.
    Dimakou K; Pachoula I; Panayotou I; Stefanaki K; Orfanou I; Lagona E; Roma-Giannikou E; Chouliaras G
    Ann Gastroenterol; 2015; 28(1):81-86. PubMed ID: 25609153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
    Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease.
    Tulewicz-Marti E; Stępień-Wrochna B; Maciejewska K; Łodyga M; Karłowicz K; Lewandowski K; Rydzewska G
    J Pers Med; 2023 May; 13(6):. PubMed ID: 37373902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
    Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
    Elonen L; Wölfle L; de Laffolie J; Posovszky C;
    Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
    Szántó K; Nyári T; Bálint A; Bor R; Milassin Á; Rutka M; Fábián A; Szepes Z; Nagy F; Molnár T; Farkas K
    PLoS One; 2018; 13(7):e0200824. PubMed ID: 30059523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
    Ranjan MK; Kante B; Vuyyuru SK; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1544-1553. PubMed ID: 35501287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study.
    Sáiz-Chumillas RM; Barrio J; Fernández-Salazar L; Arias L; Sierra Ausín M; Piñero C; Fuentes Coronel A; Mata L; Vásquez M; Carbajo A; Alcaide N; Cano N; Nuñez A; Fradejas P; Ibáñez M; Hernández L; Sicilia B
    Gastroenterol Hepatol; 2023 Feb; 46(2):102-108. PubMed ID: 35569540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study.
    Quaresma AB; Damiao AOMC; Coy CSR; Magro DO; Hino AAF; Valverde DA; Panaccione R; Coward SB; Ng SC; Kaplan GG; Kotze PG
    Lancet Reg Health Am; 2022 Sep; 13():100298. PubMed ID: 36777324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease.
    Lee SH; Shin M; Kim SH; Kim SP; Yoon HJ; Park Y; Koh J; Oh SH; Ko JS; Moon JS; Kim KM
    Pediatr Gastroenterol Hepatol Nutr; 2024 Jul; 27(4):206-214. PubMed ID: 39035400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.